Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alpine Immune Sciences Inc
(NQ:
ALPN
)
64.43
-0.03 (-0.05%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
2,485,689
Open
64.42
Bid (Size)
64.41 (17)
Ask (Size)
64.49 (1)
Prev. Close
64.46
Today's Range
64.42 - 64.48
52wk Range
6.710 - 64.57
Shares Outstanding
23,914,879
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?
Today 8:30 EDT
The biotech just added another potential growth driver to its pipeline.
Via
The Motley Fool
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 4/16
April 16, 2024
Via
Investor Brand Network
Performance
YTD
+239.11%
+239.11%
1 Month
+61.28%
+61.28%
3 Month
+232.97%
+232.97%
6 Month
+542.37%
+542.37%
1 Year
+763.67%
+763.67%
More News
Read More
Can You Afford to Ignore These 3 Biotech Stocks Up Over 160% in 2024?
April 15, 2024
Via
InvestorPlace
Here's (at Least) 1 new Reason to Buy Vertex Pharmaceuticals Stock
April 15, 2024
Via
The Motley Fool
Could This Stock Be the Next Biotech Buyout?
April 13, 2024
Via
The Motley Fool
ALPINE IMMUNE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Alpine Immune Sciences, Inc. - ALPN
April 12, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Stock Market Sends Mixed Signals; Nvidia, Inflation, Mideast Fears In Focus: Weekly Review
April 12, 2024
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Stocks Surge, Goldgasms To Record High After "Adjusted" PPI Sparks Buying Frenzy
April 11, 2024
Via
Talk Markets
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
April 11, 2024
Via
Benzinga
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
April 11, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 11, 2024
Via
Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) Near Top of Volume Charts in Thursday Trading
April 11, 2024
Via
Investor Brand Network
Enliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
April 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Alpine Immune Sciences Inc. (NASDAQ: ALPN) Records 52-Week High Thursday Morning
April 11, 2024
Via
Investor Brand Network
The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today
April 11, 2024
Via
InvestorPlace
Biotech Stocks Heat As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
April 11, 2024
Via
Investor's Business Daily
Vertex Pharmaceuticals Moves Beyond $10B Cystic Fibrosis Franchise, Pays Around $5B For Kidney Disease Player Alpine Immune
April 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
April 11, 2024
Via
Benzinga
Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity'
April 11, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
April 11, 2024
Via
InvestorPlace
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket
April 11, 2024
Via
Benzinga
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today
April 10, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders
April 10, 2024
From
Halper Sadeh LLC
Via
Business Wire
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal
April 10, 2024
Via
Investor's Business Daily
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.